4 terminated. 4 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Terminated 4 |
| Phase 2 | 3 | Terminated 3 |
Follow Foot Diseases: new trials by email Literature Review of Foot Diseases trials Research Report on Foot Diseases
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Iontophoresis of Treprostinil to Enhance Wound Healing in Diabetic Foot Skin Ulcers Treprostinil iontophoresis, Remodulin® placebo iontophoresis - Diabetic Foot Ulcer | Phase 1 / Phase 2 | Terminated | University Hospital, Grenoble | 4 | 2020-01-28 | 2023-12-12 |
| Safety and Efficacy of Gentamicin Topical Gel (AppliGel-G) for Treatment of Mild to Moderately Infected Diabetic Foot Ulcers Gentamicin Topical Gel, Ciprofloxacin, Doxycycline - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Terminated | Royer Biomedical, Inc. | 9 | 2014-01-01 | 2015-05-14 |
| Clinical Equivalence of Two Generic Butenafine Hydrochloride 1% Creams as Compared to Lotrimin Ultra Cream in Patients With Interdigital Tinea Pedis Butenafine Hydrochloride 1%, Butenafine Hydrochloride 1% B, Vehicle A - Interdigital Tinea Pedis | Phase 1 | Terminated | Sun Pharmaceutical Industries, Inc. | 428 | 2010-07-01 | 2014-05-06 |
| Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers ATG002 (study drug) - Diabetic Foot Ulcers | Phase 1 / Phase 2 | Terminated | CoMentis | 48 | 2006-10-01 | 2007-08-09 |
Diabetic Foot (3) · Foot Ulcer (3) · Diabetes Mellitus (1) · Infections (1) · Tinea Pedis (1)
Skin Diseases (4) · Skin and Connective Tissue Diseases (4) · Cardiovascular Diseases (3) · Diabetes Complications (3) · Diabetic Angiopathies (3) · Diabetic Neuropathies (3) · Endocrine System Diseases (3) · Leg Ulcer (3) · Skin Ulcer (3) · Vascular Diseases (3) · Diabetes Mellitus (2) · Bacterial Infections and Mycoses (1) · Dermatomycoses (1) · Foot Dermatoses (1)
Ciprofloxacin (1) · Doxycycline (1) · Drug Evaluation (1) · butenafine (1)
CoMentis (1) · Royer Biomedical, Inc. (1) · Sun Pharmaceutical Industries, Inc. (1) · University Hospital, Grenoble (1)
United States (2) · France (1)
Cracowski Jean-luc, Professor (1) · Henry Hsu, MD (1)